2022年美国专利用途代码 .pdf

《2022年美国专利用途代码 .pdf》由会员分享，可在线阅读，更多相关《2022年美国专利用途代码 .pdf（39页珍藏版）》请在淘文阁 - 分享文档赚钱的网站上搜索。

1、美国 FDA 药物批准数据库：http:/ 代码专利用途码释义*PEDPediatric exclusivity 儿科专用药 DPDrug Product claim 药物产品保护DSDrug Substance claim 药物物质保护DS DPDrug Substance claim & Drug Product claim 药物物质保护和产品保护U1PREVENTION OF PREGNANCY 避孕 U10DIAGNOSTIC METHOD FOR DISTINGUISHING BETWEEN HYPOTHALAMIC MALFUNCTIONS OR LESIONS IN HUMANS

2、人类下丘脑机能障碍或病变识别诊断方法U100METHOD OF TREATING OCULAR INFLAMMATION 眼部感染治疗方法U101ADJUNCT TO CONVENTIONAL CT OR MRI IMAGING IN THE LOCALIZATION OF STROKE IN PATIENTS IN WHOM STROKE HAS ALREADY BEEN DIAGNOSEDU102METHOD OF HORMONALLY TREATING MENOPAUSAL OR POST-MENOPAUSAL DISORDERS IN WOMENU103TREATMENT OF OCU

3、LAR HYPERTENSION 治疗眼压高 U104TREATMENT OF AQUEOUS HUMOR FORMATION AND INTRAOCULAR PRESSUREU105EMESIS 呕吐 U106TREATMENT OF EPILEPSY 治疗癫痫症 U107TREATMENT OF HYPERTENSION AND ANGINA PECTORIS 治疗高血压和心绞痛U108SHORT-TERM TREATMENT OF ACTIVE DUODENAL ULCER, 名师资料总结 - - -精品资料欢迎下载 - - - - - - - - - - - - - - - - - -

4、 名师精心整理 - - - - - - - 第 1 页，共 39 页 - - - - - - - - - GASTROESOPHAGEAL REFLUX DISEASE (GERD), SEVERE EROSIVE ESOPHAGITIS, POORLY RESPONSIVE SYMPTOMATIC GERD, PATHOLOGICAL HYPERSECRETORY CONDITIONS AND MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITISU109USE AS AN ADJUNCT TO DIET IN THE TREATMENT OF ELEVA

5、TED TOTAL CHOLESTEROL AND LDL-C LEVELS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA WHOSE RESPONSE TO DIETARY RESTRICTION OF SATURATED FAT AND CHOLESTEROL AND OTHER NONPHARMACOLOGICAL MEASURES HAS NOT BEEN ADEQUATEU11TREATMENT OR PROPHYLAXIS OF CARDIAC DISORDERSU110USE AS A RETRIEVABLE PESSARYU111D

6、IABETES 糖尿病 U112CONTRACEPTION 避孕方法 U113METHOD OF CONDUCTING A RADIOLOGICAL EXAMINATION OF A PATIENT BY ADMINISTERING TO SAID PATIENT A RADIOPAQUE AMOUNT OF IOPROMIDEU114USE FOR INHIBITING BONE RESORPTION用于抑制骨吸收U115USE OF VASODILATORS TO EFFECT AND ENHANCE AN ERECTION (AND THUS TREAT ERECTILE DYSFUNC

7、TION), BY INJECTION INTO THE PENISU116METHOD OF MYOCARDIAL IMAGINGU117TREATMENT OF OCULAR ALLERGIC RESPONSE IN HUMAN EYESU118METHOD OF LOWERING BLOOD SUGAR LEVELU119TREATMENT OF NASAL HYPERSECRETIONU12METHOD OF TREATING A HUMAN SUFFERING FROM DEPRESSIONU120CONTROLLING OR PREVENTING POST-OPERATIVE IN

8、TRAOCULAR PRESSURE RISES ASSOCIATED WITH OPHTHALMIC LASER SURGICAL PROCEDURESU121METHOD OF TREATING CONDITIONS MEDIATED THROUGH HISTAMINE 名师资料总结 - - -精品资料欢迎下载 - - - - - - - - - - - - - - - - - - 名师精心整理 - - - - - - - 第 2 页，共 39 页 - - - - - - - - - H2-RECEPTORSU122A THERAPEUTIC METHOD FOR CONTROLLING

9、THROMBOSISU123METHOD FOR CONTROLLING THROMBOSIS AND DECREASING BLOOD HYPERCOAGULATION AND HEMORRHAGING RISKSU124TREATMENT OF ACNE 痤疮的治疗 U125TREATING NEUROGENERATIVE DISEASESU126TREATMENT OF GASTRITIS 胃炎的治疗 U127METHOD OF PRODUCING NEUROMUSCULAR BLOCKADE 产生神经肌肉阻滞的方法U128METHODS FOR TREATMENT OF TUMORS

10、肿瘤的治疗方法U129METHOD TO DESTROY OR IMPAIR TARGET CELLS 消灭或减少靶细胞的方法U13A METHOD FOR TREATING ANXIETY IN A HUMAN SUBJECT IN NEED OF SUCH TREATMENTU130MANAGEMENT OF PATIENTS WITH MASTOCYTOSISU131PHOTODAMAGED SKINU132INHIBITING HIV PROTEASEU133MANAGEMENT OF OBESITY INCLUDING WEIGHT LOSS AND MAINTENANCE IN P

11、ATIENTS ON A REDUCED-CALORIE DIETU134TREATMENT OF ACNE VULGARISU135ANTITUMOR AGENTU136PROCESS FOR WASTE NITROGEN REMOVALU137METHOD OF TREATING BACTERIAL VAGINOSIS名师资料总结 - - -精品资料欢迎下载 - - - - - - - - - - - - - - - - - - 名师精心整理 - - - - - - - 第 3 页，共 39 页 - - - - - - - - - U138TREATMENT OF ALLERGIC RHI

12、NITISU139TREATMENT OF ALLERGIC REACTIONSU14ADJUNCTIVE THERAPY FOR THE PREVENTION AND TREATMENT OF HYPERAMMONEMIA IN THE CHRONIC MANAGEMENT OF PATIENTS WITH UREA CYCLE ENZYMOPATHIESU140USE OF NORVIR TO INHIBIT HIV PROTESASE OR TO INHIBIT AN HIV INFECTIONU141TREATMENT OF ULCERATIVE COLITISU142METHOD O

13、F TREATING ALLERGIC REACTIONS IN A MAMMAL BY USING THIS ACTIVE METABOLITEU143BIODEGRADABLE SUPERPARAMAGNETIC METAL OXIDES AS CONTRAST AGENTS FOR MR IMAGINGU144BIOLOGICALLY DEGRADABLE SUPERPARAMAGNETIC MATERIALS FOR USE IN CLINICAL APPLICATIONSU145BIOLOGICALLY DEGRADABLE SUPERPARAMAGNETIC PARTICLES F

14、OR USE AS NUCLEAR MAGNETIC RESONANCE IMAGING AGENTSU146METHOD OF TREATING SUSCEPTIBLE NEOPLASMS IN MAMMALSU147DETECTION OF GASTROINTESTINAL DISORDERS AND THE SUBSEQUENT BREATH COLLECTION AND MEASUREMENT OF 13CO2U148DEVICE FOR COLLECTING A BREATH SAMPLEU149METHOD OF TREATING AN ANIMAL, INCLUDING A HU

15、MAN SUFFERING FROM OR SUSCEPTIBLE TO PSYCHOSIS, ACUTE MANIA OR MILD ANXIETY STATESU15METHOD OF LOWERING INTRAOCULAR PRESSUREU150METHOD OF USE FOR CONTROLLING HYPERGLYCEMIA BY ADMINISTRATION OF THIS SUSTAINED RELEASE DOSAGE FORM OF GLIPIZIDEU151RELIEF OF SYMPTOMS OF THE COMMON COLD名师资料总结 - - -精品资料欢迎下

16、载 - - - - - - - - - - - - - - - - - - 名师精心整理 - - - - - - - 第 4 页，共 39 页 - - - - - - - - - U152METHOD OF TREATING ANXIETY RELATED DISORDERS INCLUDING OBSESSIVE COMPULSIVE DISORDERU153TREATMENT OF INITIAL EPISODE GENITAL HERPESU154METHOD OF TREATING ANIMALS SUFFERING FROM AN APPETITE DISORDERU155TREAT

17、MENT OF ERECTILE DYSFUNCTIONU156METHOD OF PROVIDING ANESTHESIAU157TREATMENT OF A HUMAN SUFFERING FROM VITAMIN B12 DEFICIENCYU158ANGINA心绞痛 U159TREATMENT OF INTERSTITIAL CYSTITISU16USE IN LUNG SCANNING PROCEDURESU160TREATMENT OF BACTERIAL INFECTIOUS DISEASEU161METHOD OF INHIBITING CHOLESTEROL BIOSYNTH

18、ESIS IN A PATIENTU162METHOD OF USE TO INHIBIT CHOLESTEROL SYNTHESIS IN A HUMAN SUFFERING FROM HYPERCHOLESTEROLEMIAU163METHOD OF USING TROGLITAZONE TO TREAT IMPAIRED GLUCOSE TOLERANCE TO PREVENT OR DELAY THE ONSET OF NONINSULIN-DEPENDENT DIABETES MELLITUSU164METHOD OF USING TROGLITAZONE TO PREVENT OR

19、 DELAY THE ONSET OF NONINSULIN-DEPENDENT DIABETES MELLITUS IN A DEFINED POPULATION OF PATIENTSU165TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIAU166TREATMENT OF H. PYLORI ASSOCIATED DUODENAL ULCERU167METHOD FOR TREATING HIV-1 INFECTION名师资料总结 - - -精品资料欢迎下载 - - - - - - - - - - - - - - - - - - 名

20、师精心整理 - - - - - - - 第 5 页，共 39 页 - - - - - - - - - U168METHOD OF INHIBITING LIPOXYGENASE ACTIVITY IN A MAMMAL WHICH IS THE MODE OF ACTION IN THE TREATMENT OF ASTHMAU169METHODS OF USING THE COMPOUND/DRUG PRODUCT AS A CONTRAST AGENT IN MAGNETIC RESONANCE IMAGINGU17TREATMENT OF VENTRICULAR AND SUPRAVEN

21、TRICULAR ARRHYTHMIASU170METHOD OF OBTAINING AN MR IMAGE USING THE COMPOSITION/DRUG PRODUCT AS A CONTRAST AGENTU171METHODS OF USING THE COMPOUND/DRUG PRODUCT AS AN ORAL CONTRAST AGENT IN MAGNETIC RESONANCE IMAGING OF THE GASTROINTESTINAL TRACTU172TREATMENT OF GENITAL WARTSU173ADMINISTRATION TO A HOST

22、 SUFFERING FROM GESTATIONAL DIABETESU174USE AS AN ANTIHISTAMINE AGENTU175METHOD OF TREATING MALIGNANT TUMORSU176METHOD OF TREATING A PATIENT SUFFERING FROM LISTED CONDITIONS, INCLUDING SPECIFIC PSYCHOSISU177FUNGICIDEU178FACILITATED ADHERENCE OF AGENTS TO SKINU179ENHANCED CUTANEOUS PENETRATION OF A D

23、ERMALLY-APPLIED PHARMACOLOGICALLY ACTIVE AGENTU18METHOD FOR INHIBITING GASTRIC SECRETION IN MAMMALSU180TREATMENT OF ADULT AND PEDIATRIC PATIENTS (OVER SIX MONTHS OF AGE) WITH ADVANCED HIV INFECTIONU181PRODUCING ALPHA ADRENERGIC ANTAGONISTIC ACTION IN A HOSTU182USE OF SALMETEROL IN PATIENTS WITH REVE

24、RSIBLE AIRWAY OBSTRUCTION名师资料总结 - - -精品资料欢迎下载 - - - - - - - - - - - - - - - - - - 名师精心整理 - - - - - - - 第 6 页，共 39 页 - - - - - - - - - U183TREATMENT OF CONDITIONS CAUSED BY DISTURBANCE OF NEURONAL 5HT FUNCTIONU184TREATING ALLERGIC EYE DISEASES IN HUMANSU185METHOD OF TREATING HYPERTENSION高血压治疗方法U186ME

25、THOD FOR TREATING GI DISORDERS CAUSED BY H. PYLORI WHICH COMPRISES ADMINISTRATION OF RANITIDINE BISMUTH CITRATE AND CLARITHROMYCIN FOR A GREATER THAN ADDITIVE EFFECTU187THERAPEUTIC TREATMENT OF CALCIFIC TUMORSU188TREATMENT OF H. PYLORI ASSOCIATED DUODENAL ULCERU189ENHANCEMENT OF THE BIOAVAILABILITY

26、OF THE DRUG SUBSTANCEU19TREATMENT OF INFLAMMATION炎症的治疗 U190USE OF RITONAVIR IN COMBINATION WITH ANY REVERSE TRANSCRIPTASE INHIBITORU191METHOD OF TREATMENT FOR CONTROLLING AND LOWERING INTRAOCULAR PRESSURE IN A HUMANU192USE IN TREATING ALLERGIC REACTIONSU193PSORIASIS 牛皮鲜 U194TREATING AGINA PECTORIS A

27、ND HIGH BLOOD PRESSUREU195METHOD FOR THE DIAGNOSIS OF GASTROINTESTINAL DISORDERS BY UREA ISOTOAC OR NITROGEN LABELED CARBONU196TREATMENT OF METASTIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR POSITIVE TUMORSU197USE IN COMBINATION WITH CERTAIN LHRH ANALOGUES FOR THE TREATMENT OF ADV

28、ANCED PROSTATE CANCERU198TREATMENT METASTATIC CARCINOMA OF OVARY AFTER FIRST-LINE FAILURE 名师资料总结 - - -精品资料欢迎下载 - - - - - - - - - - - - - - - - - - 名师精心整理 - - - - - - - 第 7 页，共 39 页 - - - - - - - - - OR SUBSEQUENT CHEMOTHERAPY, TREATMENT OF BREAST CANCER AFTER FAILURE OF COMBINATION CHEMOTHERAPY FOR

29、METASTATIC DISEASE AND SECOND-LINE TREATMENT OF AIDS-RELATED KAPOSI S SARCOMAU199METHOD OF TREATING INFECTIOUS UPPER GI TRACT DISORDERS CAUSED BY CAMPYLOBACTER PYLORDIS INFECTION COMPRISING ADMINISTRATION OF A BISMUTH AGENT AND AN ANTIMICROBIAL AGENTU2TREATMENT OR PROPHYLAXIS OF ANGINA PECTORIS AND

30、ARRHYTHMIAU20A PROCESS FOR TREATING A PATIENT SUFFERING FROM PARKINSONS SYNDROME AND IN NEED OF TREATMENTU200METHOD OF TREATING GI DISORDERS COMPRISING ADMINISTRATION OF A BISMUTH-CONTAINING AGENT AND H2 RECEPTOR BLOCKING ANTI-SECRETORY AGENTU201METHOD OF TREATING GI DISORDERS COMPRISING ADMINISTRAT

31、ION OF CAMPYLOBACTER-INHIBITING ANTIMICROBIAL AGENT AND H2 RECEPTOR BLOCKING ANTI-SECRETORY AGENTU202METHOD OF TREATING PEPTIC ULCER DISEASE CAUSED BY CAMPYLOBACTER PYLORIDIS COMPRISING ORAL ADMINISTRATION OF 50 TO 5,000MG BISMUTH DAILY FOR 3-56 DAYSU203TREATMENT OF ADVANCED BREAST CANCER IN POSTMEN

32、OPAUSAL WOMEN WITH DISEASE PROGRESSION FOLLOWING ANTIESTROGEN THERAPYU204USE OF TAXOL IN COMBINATION WITH G-CSF FOR TREATMENT OF PATIENTS WITH AIDS-RELATED KAPOSI S SARCOMAU205METHOD FOR TREATING HEARTBURNU206METHOD OF USING FSH ALONE, WITHOUT THE PRESENCE OF EXOGENOUS LH, IN IN VITRO FERTILIZATIONU

33、207USE AS NASAL SPRAYU208VAGINAL ADMINISTRATION USING SPECIFIED FORMULATIONU209VAGINAL ADMINISTRATION OF PROGESTERONE USING SPECIFIED 名师资料总结 - - -精品资料欢迎下载 - - - - - - - - - - - - - - - - - - 名师精心整理 - - - - - - - 第 8 页，共 39 页 - - - - - - - - - FORMULATIONU21TREATMENT OF HUMANS SUFFERING UNDESIRED URO

34、TOXIC SIDE EFFECTS CAUSED BY CYTOSTATICALLY ACTIVE ALKYLATING AGENTSU210METHOD OF TREATING CONGESTIVE HEART FAILUREU211USE IN PATIENTS WITH REVERSIBLE AIRWAY OBSTRUCTIONU212METHOD OF TREATMENT OF PARKINSON S DISEASEU213METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS AND TREATING HYPERCHOLESTEROLEMIA A

35、ND METHOD FOR TREATING HYPERLIPIDEMIAU214USE AS A BLOOD GLUCOSE-LOWERING AGENTU215TREATMENT OF EPILEPSY TWICE DAILY. TREATING A PATIENT BY ADMINISTERING CARBAMAZEPINE IN A DOSAGE FORM CAPABLE OF MAINTAINING BLOOD CONCENTRATION FROM 4-12MCG/ML OVER 12 HOURSU216TREATMENT OF ADENOCARCINOMA, INCLUDING S

36、TAGE B2-C, BY ADMINISTERING AN AGONIST OF LR-RH AND FLUTAMIDEU217METHOD OF PRODUCING ANESTHESIAU218METHOD FOR LIMITING THE POTENTIAL FOR MICROBIAL GROWTH IN THE DRUG PRODUCTU219TREATMENT OF PARKISON S DISEASEU22METHOD OF COMBATTING PATHOLOGICALLY REDUCED CEREBRAL FUNCTIONS AND PERFORMANCE WEAKNESSES

37、, CEREBRAL INSUFFICIENCY AND DISORDERS IN CEREBRAL CIRCULATION AND METABOLISM IN WARM-BLOODED ANIMALSU220METHOD OF DIAGNOSIS诊断方法 U221SELECTIVE VASODILATION BY CONTINUOUS ADENOSINE INFUSIONU222METHOD OF TREATING PAGETS DISEASE USING ACTONEL名师资料总结 - - -精品资料欢迎下载 - - - - - - - - - - - - - - - - - - 名师精心

38、整理 - - - - - - - 第 9 页，共 39 页 - - - - - - - - - U223TREATMENT OF BACTERIAL CONJUNCTIVITIS CAUSED BY SUSCEPTIBLE STRAINS OF MICROORGANISMSU224CONTROLLING INTRAOCULAR PRESSUREU225METHOD FOR DELIVERYU226METHOD OF ENHANCING THE DISSOLUTION PROFILE OF A PHARMACEUTICAL FROM A SOLID DOSAGE FORM CONTAINING

39、THE PHARMACEUTICAL AND SIMETHICONEU227NASAL ADMINISTRATIONU228ASTHMAU229CARDIAC INSUFFICIENCY (CONGESTIVE HEART FAILURE)U23METHOD FOR TREATING PROSTATIC CARCINOMA COMPRISING ADMINISTERING FLUTAMIDEU230PREVENTION OF ACUTE CARDIAC ISCHEMIC EVENTSU231USE IN PARKINSON S DISEASEU232METHOD OF TREATING MIG

40、RAINEU233DECREASING MORTALITY CAUSED BY CONGESTIVE HEART FAILUREU234METHOD OF USING RIBAVIRIN TO TREAT VIRAL INFECTIONS IN MAMMALSU235METHOD OF MODULATING TH1 AND TH2 RESPONSE IN ACTIVATED T CELLS OF A HUMAN COMPRISING ADMINISTERING RIBAVIRIN TO THE T CELLS IN A DOSAGE WHICH PROMOTES THE TH1 RESPONS

41、E AND SUPPRESSES THE TH2 RESPONSEU236TREATING MALE PATTERN BALDNESS WITH 0.05 TO 3 MG/DAYU237METHOD OF PERFORMING NMR IMAGING WITH A PATIENT COMPRISING ADMINISTERING TO THE PATIENT AN EFFECTIVE AMOUNT OF CONTRAST AGENT DISCLOSED IN THE CLAIMS名师资料总结 - - -精品资料欢迎下载 - - - - - - - - - - - - - - - - - - 名

42、师精心整理 - - - - - - - 第 10 页，共 39 页 - - - - - - - - - U238IMAGING A BODY TISSUE AND SUBJECTING TO NMR TOMOGRAPHY, ADMINISTERING AN AMOUNT OF PHARMACEUTICAL AGENT FOR AFFECTING THE RELAXATION TIMES OF ATOMS IN BODY TISSUES UNDERGOING NMR DIAGNOSIS, WHEREBY THE IMAGE CONTRAST IN ENHANCED.U239TREATING OR

43、 CONTROLLING OCULAR INFLAMMATION WHICH COMPRISES TOPICALLY ADMINISTERING TO THE AFFECTED EYE A COMPOSITION COMPRISING AN NSAID, A POLYMERIC QUATERNARY AMMONIUM COMPOUND AND BORIC ACIDU24METHOD FOR TREATING PROSTATE ADENOCARCINOMA COMPRISING ADMINISTERING AN ANTIANDROGEN INCLUDING FLUTAMIDE AND AN LH

44、RH AGONISTU240TREATMENT OF ACUTE MIGRAINE ATTACKSU241FOR SHORT-TERM TREATMENT ACTIVE DUODENAL ULCER, MAINTENANCE THERAPY FOR DUODENAL ULCER PATIENTS AT REDUCED DOSAGE AFTER HEALING OF ACTIVE ULCER, SHORT-TERM TREATMENT ACTIVE BENIGN GASTRIC ULCER & GERD, PATHOLOGICAL HYPERSECRETORY CONDITIONSU242USE

45、 OF FOLLITROPIN ALPHA ALONE IN IN-VITRO FERTILIZATIONU243TOPICAL ADMINISTRATIONU244PLATELET AGGREGATION INHIBITORSU245TREATMENT OF SEBORRHEA DERMATITIS IN HUMANSU246PHOSPHATE BINDINGU247TREATMENT OF RHEUMATOID ARTHRITISU248TREATMENT OF HIVHIV的治疗 U249METHOD OF TREATING ALLERGIC OR NON-ALLERGIC RHINIT

46、IS IN PATIENTS BY ADMINISTERING AEROSOLIZED PARTICLES OF MOMETASONE FUROATEU25REDUCING CHOLESTEROL IN CHOLELITHIASIS PATIENTSU250TREATMENT OF HEPATITIS B INFECTION名师资料总结 - - -精品资料欢迎下载 - - - - - - - - - - - - - - - - - - 名师精心整理 - - - - - - - 第 11 页，共 39 页 - - - - - - - - - U251USE OF TROGLITAZONE IN

47、COMBINATION WITH SULFONYLUREAS IN THE TREATMENT OF TYPE II DIABETESU252METHOD OF TREATING A HUMAN SUBJECT HAVING GAUCHER S DISEASEU253ORAL TRANSMUCOSAL USEU254USE OF AGGRASTAT IN COMBINATION WITH HEPARINU255IMPROVED WAKEFULNESS IN PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH NARCOLEPSY

48、U256TREATMENT OF HIV INFECITON IN COMBINATION WITH ONE OR MORE ADDITIONAL HIV ANTIVIRAL AGENTSU257TREATMENT OF HIV INFECTIONU258TREATMENT OF NEURODEGENERATIVE DISEASESU259TREATMENT OF ANDROGENIC ALOPECIA BY ORAL ADMINISTRATION OF DRUG SUBSTANCEU26REDUCING CHOLESTEROL GALLSTONES AND/OR FRAGMENTS THER

49、EOFU260REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION WHO ARE INTOLERANT OF OTHER IOP LOWERING MEDICATIONS OR INSUFFICIENTLY RESPONSIVE TO ANOTHER IOP LOWERING MEDICATIONU261TREATING BENIGN PROSTATIC HYPERPLASIA WITH A GENUS OF COMPOUNDS, INCLUDING FIN

50、ASTERIDEU262TREATING BENIGN PROSTATIC HYPERTROPHY WITH FINASTERIDEU263METHOD OF TREATING A MALIGNANT CONDITION THROUGH INTRAVASCULAR ADMINISTRATION OF BUSULFAN. METHOD FOR TREATING LEUKEMIA OR LYMPHOMA IN A PATIENT UNDERGOING A BONE MARROW TRANSPLANT THROUGH INTRAVENOUS ADMINISTRATION OF BUSULFAN.U2